Cargando…

High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique

BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Semá Baltazar, Cynthia, Horth, Roberta, Boothe, Makini, Sathane, Isabel, Young, Peter, Chitsondzo Langa, Denise, Condula, Manuel, Ricardo, Helena, Dengo Baloi, Liliana, Cummings, Beverley, Schaad, Nicolas, Gouveia, Lídia, Teodoro, Eugénia, Raymond, Henry F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889180/
https://www.ncbi.nlm.nih.gov/pubmed/31791273
http://dx.doi.org/10.1186/s12879-019-4655-2
_version_ 1783475361902755840
author Semá Baltazar, Cynthia
Horth, Roberta
Boothe, Makini
Sathane, Isabel
Young, Peter
Chitsondzo Langa, Denise
Condula, Manuel
Ricardo, Helena
Dengo Baloi, Liliana
Cummings, Beverley
Schaad, Nicolas
Gouveia, Lídia
Teodoro, Eugénia
Raymond, Henry F.
author_facet Semá Baltazar, Cynthia
Horth, Roberta
Boothe, Makini
Sathane, Isabel
Young, Peter
Chitsondzo Langa, Denise
Condula, Manuel
Ricardo, Helena
Dengo Baloi, Liliana
Cummings, Beverley
Schaad, Nicolas
Gouveia, Lídia
Teodoro, Eugénia
Raymond, Henry F.
author_sort Semá Baltazar, Cynthia
collection PubMed
description BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHODS: We used respondent-driven sampling (RDS) to conduct a cross-sectional behavioral surveillance survey of PWID in two cities of Mozambique lasting six months. Participants were persons who had ever injected drugs without a prescription. Participants completed a behavioral questionnaire and provided blood specimens for HIV, hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) testing. We performed RDS-adjusted analysis in R 3.2 using RDSAT 7.1 weights. RESULTS: We enrolled 353 PWID in Maputo and 139 in Nampula/Nacala; approximately 95% of participants were men. Disease prevalence in Maputo and Nampula/Nacala, respectively, was 50.1 and 19.9% for HIV, 32.1 and 36.4% for HBsAg positivity, and 44.6 and 7.0% for anti-HCV positivity. Additionally, 8% (Maputo) and 28.6% (Nampula/Nacala) of PWID reported having a genital sore or ulcer in the 12 months preceding the survey. Among PWID who injected drugs in the last month, 50.3% (Maputo) and 49.6% (Nampula/Nacala) shared a needle at least once that month. Condomless sex in the last 12 months was reported by 52.4% of PWID in Maputo and 29.1% in Nampula/Nacala. Among PWID, 31.6% (Maputo) and 41.0% (Nampula/Nacala) had never tested for HIV. In multivariable analysis, PWID who used heroin had 4.3 (Maputo; 95% confidence interval [CI]: 1.2, 18.2) and 2.3 (Nampula/Nacala; 95% CI: 1.2, 4.9) greater odds of having HIV. CONCLUSION: Unsafe sexual behaviors and injection practices are frequent among PWID in Mozambique, and likely contribute to the disproportionate burden of disease we found. Intensified efforts in prevention, care, and treatment specific for PWID have the potential to limit disease transmission.
format Online
Article
Text
id pubmed-6889180
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68891802019-12-11 High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique Semá Baltazar, Cynthia Horth, Roberta Boothe, Makini Sathane, Isabel Young, Peter Chitsondzo Langa, Denise Condula, Manuel Ricardo, Helena Dengo Baloi, Liliana Cummings, Beverley Schaad, Nicolas Gouveia, Lídia Teodoro, Eugénia Raymond, Henry F. BMC Infect Dis Research Article BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHODS: We used respondent-driven sampling (RDS) to conduct a cross-sectional behavioral surveillance survey of PWID in two cities of Mozambique lasting six months. Participants were persons who had ever injected drugs without a prescription. Participants completed a behavioral questionnaire and provided blood specimens for HIV, hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) testing. We performed RDS-adjusted analysis in R 3.2 using RDSAT 7.1 weights. RESULTS: We enrolled 353 PWID in Maputo and 139 in Nampula/Nacala; approximately 95% of participants were men. Disease prevalence in Maputo and Nampula/Nacala, respectively, was 50.1 and 19.9% for HIV, 32.1 and 36.4% for HBsAg positivity, and 44.6 and 7.0% for anti-HCV positivity. Additionally, 8% (Maputo) and 28.6% (Nampula/Nacala) of PWID reported having a genital sore or ulcer in the 12 months preceding the survey. Among PWID who injected drugs in the last month, 50.3% (Maputo) and 49.6% (Nampula/Nacala) shared a needle at least once that month. Condomless sex in the last 12 months was reported by 52.4% of PWID in Maputo and 29.1% in Nampula/Nacala. Among PWID, 31.6% (Maputo) and 41.0% (Nampula/Nacala) had never tested for HIV. In multivariable analysis, PWID who used heroin had 4.3 (Maputo; 95% confidence interval [CI]: 1.2, 18.2) and 2.3 (Nampula/Nacala; 95% CI: 1.2, 4.9) greater odds of having HIV. CONCLUSION: Unsafe sexual behaviors and injection practices are frequent among PWID in Mozambique, and likely contribute to the disproportionate burden of disease we found. Intensified efforts in prevention, care, and treatment specific for PWID have the potential to limit disease transmission. BioMed Central 2019-12-02 /pmc/articles/PMC6889180/ /pubmed/31791273 http://dx.doi.org/10.1186/s12879-019-4655-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Semá Baltazar, Cynthia
Horth, Roberta
Boothe, Makini
Sathane, Isabel
Young, Peter
Chitsondzo Langa, Denise
Condula, Manuel
Ricardo, Helena
Dengo Baloi, Liliana
Cummings, Beverley
Schaad, Nicolas
Gouveia, Lídia
Teodoro, Eugénia
Raymond, Henry F.
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title_full High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title_fullStr High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title_full_unstemmed High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title_short High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
title_sort high prevalence of hiv, hbsag and anti-hcv positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in mozambique
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889180/
https://www.ncbi.nlm.nih.gov/pubmed/31791273
http://dx.doi.org/10.1186/s12879-019-4655-2
work_keys_str_mv AT semabaltazarcynthia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT horthroberta highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT boothemakini highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT sathaneisabel highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT youngpeter highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT chitsondzolangadenise highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT condulamanuel highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT ricardohelena highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT dengobaloililiana highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT cummingsbeverley highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT schaadnicolas highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT gouveialidia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT teodoroeugenia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique
AT raymondhenryf highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique